Metabolomic Signature of Exogenous Ketosis
KM
The Effect of Acute Exogenous Oral Ketone Supplementation on the Plasma Metabolomic Signature in Healthy Individuals: An Exploration of Novel Ketone-derived Metabolites
1 other identifier
interventional
5
1 country
1
Brief Summary
Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, how ketone supplements impact metabolism is not fully understood but using high throughput analysis techniques that can characterize hundreds to thousands of metabolites in the blood (known as "metabolomics") may allow researchers to discover novel compounds within the body that are altered by ketone supplements. This will improve our understanding of how ketones impact metabolism and guide future research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedMay 16, 2023
May 1, 2023
2 months
December 21, 2022
May 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Beta-hydroxybutyrate-derived metabolites
Metabolites derived from the enzymatic conjugation of beta-hydroxybutyrate to amino acids
90 minutes
Study Arms (1)
Ketone monoester
EXPERIMENTAL0.75 g/kg body mass of ketone monoester to be consumed within 5 minutes with venous blood samples obtained pre-ingestion, and 30-, 60- and 90-minutes post-ingestion.
Interventions
Participants will consume a ketone monoester drink (0.75 k/kg body mass) with venous blood samples obtained before and after (30, 60 and 90 minutes) drink consumption.
Eligibility Criteria
You may qualify if:
- over the age of 18 years
- able to fast overnight
You may not qualify if:
- being a competitive endurance athlete
- following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regular consuming ketone supplements
- being unable to travel to and from the university
- being pregnant or planning to become pregnant during the study
- having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease
- being unable to read or communicate in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- Stanford Universitycollaborator
Study Sites (1)
University of British Columbia
Kelowna, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 21, 2022
First Posted
January 26, 2023
Study Start
February 1, 2023
Primary Completion
April 1, 2023
Study Completion
April 1, 2023
Last Updated
May 16, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will share
The investigators will share individual patient data (de-identified) with researchers upon request.